Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine versus low-dose neostigmine for post-cesarean pain relief under spinal anesthesia
IRCT20210904052371N4Phase 3Completed
- Sponsor
- Mazandaran University of Medical Sciences
- Start
- Aug 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in postoperative pain comparing Neostigmine + bupivacaine with Dexmedetomidine + bupivacaine (2 arms). Primary endpoint: Pain intensity. Started Aug 2023; status: completed.
02
Drugs
dexmedetomidineneostigminebupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on IRCT20210904052371N4.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20210904052371N4.